Douglas M. Hunt - Nov 2, 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role: The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.
Signature: /s/ Gordon Esplin as attorney-in-fact for Douglas M. Hunt
Stock symbol: PBYI
Transactions as of: Nov 2, 2022
Transactions value $: -$965
Form type: 4
Date filed: 11/4/2022, 04:19 PM
Previous filing: Oct 5, 2022
Next filing: Dec 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBYI	Common Stock	Sale	-$965	-429	-0.56%	$2.25	76K	Nov 2, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.

Remarks:

The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.